文献速递心力衰竭与心肌病肺血管病与心包/心肌炎

射血分数保留的心力衰竭中肺动脉高压的神经激素基础

The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.
PubMed 文献 · Eur Heart J · 2019-01-01

本研究探索射血分数保留的心力衰竭(HFpEF)合并肺动脉高压(PH)的神经激素机制,发现内皮素和肾上腺髓质素通路激活,其水平与肺动脉压力、肺毛细血管楔压、右心室功能储备及运动能力受损相关。

要点

  • HFpEF患者内皮素和肾上腺髓质素水平升高,与肺动脉高压严重程度相关。
  • 神经激素水平与右心室舒张储备、心输出量反应及峰值耗氧量受损相关。
  • 针对这些通路的治疗可能改善HFpEF-PH表型患者的预后,需进一步研究。

核心结论

  • HFpEF患者存在内皮素和肾上腺髓质素通路激活,其激活程度与肺血流动力学异常、右心室功能储备受限、心输出量减少及运动能力受损相关。

研究设计与样本

  • 前瞻性研究,纳入侵入性验证的HFpEF患者38例和无心衰对照20例,测量静息和运动时血浆C端内皮素原1和中间区域肾上腺髓质素原水平、中心血流动力学、超声心动图和耗氧量。

主要发现

  • HFpEF患者静息和运动时CT-proET-1和MR-proADM水平均高于对照组。
  • CT-proET-1和MR-proADM与平均肺动脉压力(r=0.73和0.65,均P<0.0001)和肺毛细血管楔压(r=0.67和0.62,均P<0.0001)强相关,与肺动脉顺应性负相关(r=-0.52和-0.43,均P<0.001)。
  • 基线CT-proET-1和MR-proADM与右心室舒张储备(ΔRV e',r=-0.59和-0.67,均P<0.001)、运动心输出量反应(r=-0.59和-0.61,均P<0.0001)及峰值耗氧量(r=-0.60和-0.67,均P<0.0001)相关。

临床怎么用

  • 在HFpEF合并肺动脉高压患者中,检测内皮素和肾上腺髓质素通路激活可能有助于评估血流动力学异常和运动能力受限程度。
  • 针对内皮素和肾上腺髓质素通路的治疗策略可能改善HFpEF-PH表型患者的预后,但需进一步研究验证因果关系和疗效。

局限性

  • 研究为观察性设计,不能确定因果关系;样本量较小(HFpEF 38例,对照20例);需进一步研究验证靶向治疗的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Pulmonary hypertension (PH) represents an important phenotype among the broader spectrum of patients with heart failure with preserved ejection fraction (HFpEF), but its mechanistic basis remains unclear. We hypothesized that activation of endothelin and adrenomedullin, two counterregulatory pathways important in the pathophysiology of PH, would be greater in HFpEF patients with worsening PH, and would correlate with the severity of haemodynamic derangements and limitations in aerobic capacity and cardiopulmonary reserve. METHODS AND RESULTS: Plasma levels of C-terminal pro-endothelin-1 (CT-proET-1) and mid-regional pro-adrenomedullin (MR-proADM), central haemodynamics, echocardiography, and oxygen consumption (VO2) were measured at rest and during exercise in subjects with invasively-verified HFpEF (n = 38) and controls free of HF (n = 20) as part of a prospective study. Plasma levels of CT-proET-1 and MR-proADM were highly correlated with one another (r = 0.89, P < 0.0001), and compared to controls, subjects with HFpEF displayed higher levels of each neurohormone at rest and during exercise. C-terminal pro-endothelin-1 and MR-proADM levels were strongly correlated with mean pulmonary artery (PA) pressure (r = 0.73 and 0.65, both P < 0.0001) and pulmonary capillary wedge pressure (r = 0.67 and r = 0.62, both P < 0.0001) and inversely correlated with PA compliance (r = -0.52 and -0.43, both P < 0.001). As compared to controls, subjects with HFpEF displayed right ventricular (RV) reserve limitation, evidenced by less increases in RV s' and e' tissue velocities, during exercise. Baseline CT-proET-1 and MR-proADM levels were correlated with worse RV diastolic reserve (ΔRV e', r = -0.59 and -0.67, both P < 0.001), reduced cardiac output responses to exercise (r = -0.59 and -0.61, both P < 0.0001), and more severely impaired peak VO2 (r = -0.60 and -0.67, both P < 0.0001). CONCLUSION: Subjects with HFpEF display activation of the endothelin and adrenomedullin neurohormonal pathways, the magnitude of which is associated with pulmonary haemodynamic derangements, limitations in RV functional reserve, reduced cardiac output, and more profoundly impaired exercise capacity in HFpEF. Further study is required to evaluate for causal relationships and determine if therapies targeting these counterregulatory pathways can improve outcomes in patients with the HFpEF-PH phenotype. CLINICAL TRIAL REGISTRATION: NCT01418248; https://clinicaltrials.gov/ct2/results? term=NCT01418248&Search=Search.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Obokata M, Kane GC, Reddy YNV, et al. The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction. Eur Heart J. 2019. PMID: 31513270. doi:10.1093/eurheartj/ehz626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。